NASDAQ:SMMT

Summit Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy SMMT

*Your capital is at risk

$15.07

+0.210 (+1.41%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

SMMT Prediction Chart

SMMT Predictions History

Latest community submissions for SMMT.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
brendandelaney73.227258	Dec 29, 2022	Bullish	$5.31	V	—	1
JS Pro	Sep 2, 2022	$1.33 +2.31%	$1.28	X	96.09%	0
phillyska.262058	Sep 2, 2022	Bullish	$1.28	V	—	0
JS Pro	May 8, 2020	$3.30 -3.23%	$3.41	X	96.77%	1
NameNotImportant Pro	May 6, 2019	$1.99 +13.07%	$1.76	X	86.93%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SMMT with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT SUMMIT THERAPEUTICS PLC

Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, fo...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by